ArticleCancer letters2018

Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.

Bharat K R Chaganty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.